Excerpts

These results establish daratumumab as the first agent to demonstrate an improvement in overall survival with a favorable trend in high-risk SMM, supporting a paradigm shift away from watchful waiting toward early intervention in this patient population.

Several combinations involving cardiac calcification metrics and lung densitometry variables yielded highly significant models, while V37 Gy was never retained among the two best discriminative features.

A positive trend toward a decrease in breast cancer mortality is noted in the most developed countries [ 2 ].

However, a systematic Cochrane review that included two trials combining PD-1 inhibitors and five trials combining PD-L1 inhibitors, with a total of 4341 participants, demonstrated that combining checkpoint inhibitors with chemotherapy before breast cancer surgery improves pathological response, event-free survival (EFS), and overall survival (OS) in early triple-negative breast cancer (TNBC), while having marginal significance in the adjuvant setting [ 62 ].

In head and neck cancer, patients showed a trend toward better outcomes with high PD-L1 expression.

By contrast, oncogenic driver identity provided outcome-relevant biological stratification independent of age: RET fusions, NTRK1/3 fusions, and BRAF V600E were associated with significantly higher odds of a non-excellent response after adjustment, whereas RAS-mutant tumors showed a favorable trend and DICER1-mutant cases achieved excellent outcomes in the modeled cohort.

Patients with p53 wild-type tumors showed a trend toward longer PFS compared with those with p53-abnormal tumors; however, the difference did not reach statistical significance (log-rank test, p = 0.128).

Hence, DEX may mediate the remodeling of local RAS signaling, which may be significant in overall survival and disease-free survival.

Overall, in SKOV3 cells, short-term DEX exposure tended to reduce angiotensin receptor expression, whereas prolonged treatment showed a trend toward increased expression, although these changes were not statistically significant.

In this pooled analysis, the survival benefit of ICIs was only marginally significant (HR 0.84, 95% CI 0.70–1), and no pooled results were available by cancer type.

Non-mitochondrial respiration (Δ0.79 pmol/min/Norm; unit, p -value = 0.053) and maximal respiration (Δ4.01 pmol/min/Norm; unit, p -value = 0.097) showed a decreasing trend in tCM, yet no differences were observed in coupling efficiency between cCM and tCM ( Supplementary Figure S8 ).

The analysis, although indirectly—as it was based on the type of procedure—showed a strong tendency towards statistical significance and a substantial effect size, indicating that over 20% of the variability in microbial composition could be explained by the factor studied.

Within this cohort, Ho-166 TARE showed a numerical trend toward improved PFS; however, no statistically significant differences in OS or PFS were observed between treatment groups in either univariable or multivariable analyses.

In patients aged ≥ 60 years, sEV-vWF levels also showed an increasing trend in HNSCC compared with benign, although this did not reach statistical significance ( p = 0.0897), likely due to the limited number of benign samples in this age group ( n = 4) ( Figure S3A ).

In contrast, topics t_9 (Clinical Cases and Studies on Specific Skin Tumors), t_10 (Cancer Risks and Studies in Transplant Recipients), and t_11(Tumors Related to Hair Follicles and Immunohistochemical Markers) for the evaluated countries displayed either a negative trend, fluctuating trends, or no prominent trends at all. 3.8.

Overall, as indicated in Figure 7 , topic t_5 (Evidence-Based Dermatology Practices and Guidelines) showed a positive trend in most of the evaluated countries (20 out of 30).

Furthermore, though none of the other genes studied changed significantly (save the internal positive control of p53R2), dGK and R1 bordered on significance in directions consistent with Figure 2 , Figure 3 and Figure 4 .

More interestingly was the fact that in the setting of stable disease after 6 cycles, those treated with maintenance cetuximab compared with no-maintenance showed a trend, although non-significant, for longer TTP of 9.2 vs. 6.6 ( p = 0.10), and OS of 19.8 vs. 7.7 ( p = 0.22).

A second contemporaneous study, D9902A, in which enrollment was 44 discontinued early (N = 98), showed a trend towards improved survival, which did not reach statistical 45 significance.The treatment effect remained strong after performing adjustments for imbalances in baseline prognostic factors, post study treatment chemotherapy use, and non-prostate cancer-related deaths and suggested a favorable risk-benefit ratio for sipuleucel-T in patients with advanced prostate cancer [ 23 ].

Treatment for 12 consecutive days, starting when a 20 mg tumor was already present, resulted in a highly significant improvement of survival.

We showed a trend of significant difference in the overall survival of patients with a methylated MGMT promoter, compared to those with an unmethylated promoter.

Subsequently, the authors combined RNAi against STAT3 and ErbB2 with irradiation in an U251 xenograft mouse model, which led to a highly significant inhibition of tumor growth compared to single RNAi treatment without toxic effects in normal astrocytes from the brain of Wistar rats [ 45 ].

[ 67 ] found that when comparing the highest and lowest tertiles, non-fasting serum insulin concentrations showed a trend, although not statistically significant at the 0.05 level, for a positive correlation with breast cancer mortality in postmenopausal (odds ratio, 1.9; 95% confidence interval, CI, 0.7–6.6, p trend = 0.10), but not premenopausal (odds ratio, 0.9; 95% CI, 0.3–2.9, p trend = 0.75) women.

Liver tumor tissues manifested significant decreases in SOD1 and CAT and, like lung, a highly significant increase in G6PD ( Figure 3 A and lower panels of Figure 3 C).

Conversely, the south exhibited the lowest rates compared to all other regions for both sexes, albeit with an increasing trend ( Figure 4 ; Table 1 ).